| 2005 Scleroderma
Foundation Research Grant Awardees |
| Investigator |
Institution |
Project Title |
Grant Duration |
Amt Granted |
| David Askew, Ph.D., new investigator |
Case Western Reserve University
Cleveland, Ohio |
“APC-T Cell Interactions in Sclerodermatous
Graft Versus Host Disease” |
Three Years |
$150,000 |
| Galina Bogatkevich, M.D.,
Ph.D., new investigator |
Medical University of South
Carolina
Charleston, S.C. |
“Functional Proteomics of CTGF-Induced
SSc Lung Fibroblasts” |
Three Years |
$150,000 |
| Edwin Chan, M.D., FRCPC,
new investigator, renewal award |
New York University School
of Medicine
New York, N.Y. |
“Purinergic Modulation of Dermal
Fibrosis” |
Two Years |
$100,000 |
Bashar Kahaleh,
M.D., new investigator
Mark Flapan Award (presented to the investigator with
the highest scoring proposal) |
Medical College
of Ohio
Toledo, Ohio |
“Epigenetics and Pathogenesis
of Scleroderma” |
Two Years |
$150,000 |
| Margaret Markiewicz, M.D.,
new investigator |
Medical University of South
Carolina
Charleston, S.C. |
“Role of TGF-beta and CTGF and
the Process of New Vessel Formation in Scleroderma” |
Three Years |
$150,000 |
| Timothy Quan, M.D., new investigator |
Yale University School of
Medicine
New Haven, Conn. |
“Role of Peripheral Blood Fibrocytes
in Nephrogenic Fibrosing Dermopathy” |
Three Years |
$150,000 |
Mitchell Watsky,
Ph.D., established investigator,
Marta Marx Award for the eradication of Scleroderma (presented
to the investigator with the second highest scoring proposal) |
University of
Tennessee Health Science Center
Memphis, Tenn. |
“C1 Channel Activity
and Function in Systemic Sclerosis Myofibroblasts” |
Two Years |
$150,000 |
| |
|
|
Total Granted: |
$1,000,000 |
